OGN Organon & Co
Price (delayed)
$10.63
Market cap
$2.74B
P/E Ratio
3.16
Dividend/share
$1.12
EPS
$3.36
Enterprise value
$10.95B
Highlights
The price to earnings (P/E) is 26% less than the last 4 quarters average of 4.5
The revenue has increased by 2.2% year-on-year
Organon's net income has decreased by 34% from the previous quarter and by 16% YoY
The company's EPS fell by 34% QoQ and by 16% YoY
Key stats
What are the main financial stats of OGN
Market
Valuations
Earnings
Shares outstanding
257.95M
Market cap
$2.74B
Enterprise value
$10.95B
Price to earnings (P/E)
3.16
Price to book (P/B)
5.8
Price to sales (P/S)
0.43
EV/EBIT
8.25
EV/EBITDA
6.82
EV/Sales
1.71
Revenue
$6.4B
Gross profit
$3.72B
Operating income
$1.37B
Net income
$864M
EBIT
$1.33B
EBITDA
$1.6B
Free cash flow
$768M
Per share
Balance sheet
Liquidity
EPS
$3.36
EPS diluted
$3.33
Free cash flow per share
$2.99
Book value per share
$1.83
Revenue per share
$24.91
TBVPS
$27.26
Total assets
$13.1B
Total liabilities
$12.63B
Debt
$8.88B
Equity
$472M
Working capital
$1.63B
Debt to equity
18.81
Current ratio
1.6
Quick ratio
0.75
Net debt/EBITDA
5.12
Margins
Efficiency
Dividend
EBITDA margin
25.1%
Gross margin
58%
Net margin
13.5%
Operating margin
21.5%
Return on assets
6.9%
Return on equity
298.7%
Return on invested capital
10.8%
Return on capital employed
12.8%
Return on sales
20.7%
Dividend yield
10.54%
DPS
$1.12
Payout ratio
33.3%
OGN stock price
How has the Organon stock price performed over time
Intraday
-4.41%
1 week
-5.93%
1 month
-30.93%
1 year
-40.35%
YTD
-28.75%
QTD
-28.61%
Financial performance
How have Organon's revenue and profit performed over time
Revenue
$6.4B
Gross profit
$3.72B
Operating income
$1.37B
Net income
$864M
Gross margin
58%
Net margin
13.5%
Organon's net income has decreased by 34% from the previous quarter and by 16% YoY
Organon's net margin has decreased by 33% from the previous quarter and by 17% YoY
The company's operating income rose by 9% YoY and by 2.8% QoQ
OGN's operating margin is up by 7% year-on-year and by 2.9% since the previous quarter
Growth
What is Organon's growth rate over time
Valuation
What is Organon stock price valuation
P/E
3.16
P/B
5.8
P/S
0.43
EV/EBIT
8.25
EV/EBITDA
6.82
EV/Sales
1.71
The company's EPS fell by 34% QoQ and by 16% YoY
The price to earnings (P/E) is 26% less than the last 4 quarters average of 4.5
The P/B is 84% less than the last 4 quarters average of 38.8
The equity is down by 4.3% QoQ
The price to sales (P/S) is 36% lower than the last 4 quarters average of 0.7
The revenue has increased by 2.2% year-on-year
Efficiency
How efficient is Organon business performance
The return on equity has dropped by 65% since the previous quarter
The ROA has declined by 36% since the previous quarter and by 24% year-on-year
The company's return on sales rose by 8% YoY
The return on invested capital is up by 6% year-on-year
Dividends
What is OGN's dividend history
DPS
$1.12
Dividend yield
10.54%
Payout ratio
33.3%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Organon financials performed over time
OGN's total assets is 3.7% more than its total liabilities
The quick ratio has contracted by 15% from the previous quarter and by 11% YoY
OGN's total assets is up by 9% YoY and by 2.7% from the previous quarter
The debt to equity has soared by 115% YoY and by 6% from the previous quarter
The equity is down by 4.3% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.